These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3188982

  • 1. Effects of nicotinic acid on concentrations of serum apolipoproteins B, C-I, C-II, C-III and E in hyperlipidemic patients.
    Wahlberg G, Holmquist L, Walldius G, Annuzzi G.
    Acta Med Scand; 1988; 224(4):319-27. PubMed ID: 3188982
    [Abstract] [Full Text] [Related]

  • 2. Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia.
    Annuzzi G, Holmquist L, Carlson LA.
    Scand J Clin Lab Invest; 1989 Feb; 49(1):73-81. PubMed ID: 2727620
    [Abstract] [Full Text] [Related]

  • 3. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.
    Knopp RH, Walden CE, Warnick GR, Albers JJ, Ginsberg J, McGinnis BM.
    Am J Med; 1987 Nov 27; 83(5B):75-84. PubMed ID: 3120587
    [Abstract] [Full Text] [Related]

  • 4. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?
    Lecomte E, Herbeth B, Paille F, Steinmetz J, Artur Y, Siest G.
    Clin Chem; 1996 Oct 27; 42(10):1666-75. PubMed ID: 8855152
    [Abstract] [Full Text] [Related]

  • 5. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS.
    J Clin Endocrinol Metab; 1982 Jun 27; 54(6):1210-5. PubMed ID: 7076797
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein profile in healthy males and its relation to maximum aerobic capacity (MAC).
    Berg A, Frey I, Keul J.
    Clin Chim Acta; 1986 Dec 15; 161(2):165-71. PubMed ID: 3100105
    [Abstract] [Full Text] [Related]

  • 7. [The serum lipid and apolipoprotein levels of middle-aged male hyperlipidemics in Chengdu district].
    Fu M, Liu B, Wu Z, Fan P, Xie G, Liu Y, Zhang R.
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar 15; 28(1):10-3. PubMed ID: 10684053
    [Abstract] [Full Text] [Related]

  • 8. Activity of low-density lipoprotein receptors as estimated from concentrations of apolipoprotein B and C-II in serum.
    Ito H, Naito C, Hayashi H, Kawamura M.
    Clin Chem; 1988 Nov 15; 34(11):2224-7. PubMed ID: 3141083
    [Abstract] [Full Text] [Related]

  • 9. [Effects of age and gender on serum levels of apolipoprotein A-I, A-II, B, C-II, C-III and E, measured by turbidimetric immunoassay, in normolipidemic Japanese elderly].
    Sato T, Ito H, Akiyama K, Shiraki M, Kita M, Noma A.
    Nihon Ronen Igakkai Zasshi; 1990 May 15; 27(3):343-50. PubMed ID: 2120491
    [Abstract] [Full Text] [Related]

  • 10. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, Laughlin LO.
    Am J Cardiol; 1995 Jun 01; 75(16):1124-9. PubMed ID: 7762498
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Chan DC, Watts GF, Nguyen MN, Barrett PH.
    Arterioscler Thromb Vasc Biol; 2006 Mar 01; 26(3):590-6. PubMed ID: 16410456
    [Abstract] [Full Text] [Related]

  • 15. Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism.
    Starck M, Schiele F, Herbeth B, Vincent-Viry M, Beaud B, Siest G, Visvikis S.
    Atherosclerosis; 2001 Apr 01; 155(2):509-16. PubMed ID: 11254923
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins.
    Ishigami M, Yamashita S, Sakai N, Hirano K, Hiraoka H, Nakamura T, Matsuzawa Y.
    Atherosclerosis; 2003 Jun 01; 168(2):359-66. PubMed ID: 12801620
    [Abstract] [Full Text] [Related]

  • 17. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
    Breckenridge WC, Alaupovic P, Cox DW, Little JA.
    Atherosclerosis; 1982 Aug 01; 44(2):223-35. PubMed ID: 7138621
    [Abstract] [Full Text] [Related]

  • 18. Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects.
    Huff MW, Fidge NH, Nestel PJ, Billington T, Watson B.
    J Lipid Res; 1981 Nov 01; 22(8):1235-46. PubMed ID: 7320634
    [Abstract] [Full Text] [Related]

  • 19. Serum concentrations of apolipoproteins in patients with thyroid dysfunction.
    Tada H, Irie Y, Yagoro A, Ohya H, Hayashi S, Fushimi R, Tamaki H, Amino N.
    Thyroidology; 1994 Dec 01; 6(3):93-7. PubMed ID: 7545001
    [Abstract] [Full Text] [Related]

  • 20. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.
    Singh AB, Hsia S, Alaupovic P, Sinha-Hikim I, Woodhouse L, Buchanan TA, Shen R, Bross R, Berman N, Bhasin S.
    J Clin Endocrinol Metab; 2002 Jan 01; 87(1):136-43. PubMed ID: 11788637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.